BCG vaccine is safe, kovid does not increase risk: study

BCG vaccine is safe, kovid does not increase risk: study

Let’s Start this Interesting Article Shared on

London: The Basil Calumet-Guérin or BCG vaccine, originally created against tuberculosis, has a general stimulant effect on the immune system and is therefore effective against Kovid-19, the researchers say.
The study, published in the journal Cell Reports Medicine, compared groups of volunteers who received the BCG vaccine in the last five years (before the Corona epidemic), indicating that the vaccine is safe and likely affects Kovid-19 symptoms. .
“It is very important to confirm that the person who has been vaccinated with BCG does not have any symptoms increase during the Kovid-19 pandemic,” said study researcher Mihai Netea from Redboud University in the Netherlands.
The BCG vaccine is the most widely received vaccine in the world. Originally intended to treat tuberculosis, it later became clear that it gave a long-lasting, normal boost to the innate immune system.
Therefore the vaccine was also effective against other conditions. In stream studyThe research team researched these effects as “trained immunity”.
The 300BCG ‘study is a result of their work, in which a group of healthy volunteers received the BCG vaccine and thus could be compared to a group of healthy volunteers who did not.
Most volunteers received the vaccine between April 2017 and June 2018. The purpose of that study was to determine differences in immune response, but now that the corona epidemic is present, the same subjects were questioned as to whether it had any effect. Vaccine on the symptoms caused by SARS-CoV-2 virus infection.
It is safe, perhaps a positive effect, the study showed. During the first wave of the Kovid-19 epidemic among the Netherlands, comparisons across groups showed that people who did not receive the vaccine did not have more symptoms, did not get sick more often or had more severe forms. Did not get sick from.
The incidence of extreme fatigue is also lower among the BCG-vaccinated group in the March – May 2020 period, with lower numbers of sick people, and vaccinated individuals.
Researchers underline that this was to be expected given the well-known effects of the BCG vaccine on healthy volunteers.
“Although we see less disease in those who have undergone BCG vaccination, only ongoing future BCG vaccination studies can determine whether this vaccination can help against Kovid-19,” Netia said.
Recently, another study published in the journal Science Advances showed that BCG vaccination could be effective in the fight against Kovid-19.


Leave a Reply

Your email address will not be published. Required fields are marked *